Report on the Annual General Meeting of Affitech A/S
Copenhagen, 28th April, 2011
Affitech A/S, (Nasdaq OMX: AFFI), the antibody medicines company, today announced that the Annual General Meeting of the Company was held on Thursday April 28th in Copenhagen at 10:00 am.

The matters decided at the Annual General Meeting were as follows:
• The Board of Directors presented the Annual Report, this was adopted and the discharge of the board of Directors and the Management board was approved
• The Board of Directors' proposal that losses for the year be carried forward to the following year was approved
• The Board of Directors' motion to authorize the board of directors to acquire own shares was adopted
• The Board of Directors' motion to change the company's currently effective general guidelines for incentive payment for the Board of Directors and executive management of Affitech A/S and remuneration policy was adopted
• Aleksandr Shuster, Andrei Petrov and Keith McCullagh were re-elected to the Board of Directors. Viktor Kharitonin, Pål Rødseth and Arne Handeland resigned, and Steven Morell, Igor Fisch and Yegor S. Vassetzky were elected as new members of the Board of Directors.
•  Ernst & Young  was elected as the Company's state authorized public accountant.
• The chairman of the meeting was authorized to file any resolutions required to be registered with the Commerce and Companies Agency.
 
Following the General Meeting, the newly elected Board of Directors met and elected Aleksandr Shuster as Chairman and Keith McCullagh as Vice Chairman.